TICKERNERD
Menu
IOSPIOSPBasic Materials · Specialty Chemicals

IOSP Stock Forecast: Innospec, Inc. Price Predictions for 2026-2027

Last close, 23 Oct 2026
$99
−0.03% on the day

The 3 Wall Street analysts covering Innospec, Inc. hold a median 12-month price target of $100 — +1.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 84 of 100 as at 24 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$2.4B
Ticker Nerd rank
84/ 100
Median analyst target
$100
Analysts covering
3
Revenue$491.4M+11.8% y/y
Operating income$39.8M
Net income$31.2M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+1.9%
1M
+2.1%
YTD
+30.4%
1Y
+33.4%
From 52W high
−1.0%
From 52W low
+51.4%
$65
$100
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

IOSP stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Innospec, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 24 Oct 2026
84/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
81
Issuance
80
Momentum
76
Revisions
75
Value
74
Quality
72
Growth
62
Accruals
36
Size
32

Volatility (81): The share price has been relatively steady.

Accruals (36): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (32): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

IOSP stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on IOSP, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$60$70$80$90$100$110Jan 26Apr 26Jul 26Oct 26IOSPHigh $110Median $100Low $93

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $93Median $100High $110

The green dot is the last close — the median target sits +1.4% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
18 Nov 2025Freedom Capital MarketsInitiatesBuy$93
21 Apr 2025Seaport GlobalUpgradeBuy—
30 Mar 2022Seaport GlobalInitiatesNeutral—
4 Sept 2019CL KingInitiatesBuy—
12 Apr 2019KeybancDowngradeSector Weight—
12 Apr 2019KeyBancDowngradeSector Weight—
16 Nov 2018KeybancMaintainsOverweight—
16 Nov 2018KeyBancMaintainsOverweight—
13 July 2018KeybancMaintainsOverweight—
13 July 2018KeyBancMaintainsOverweight—
24 Apr 2018Johnson RiceUpgradeBuy—
14 Nov 2017Johnson RiceUpgradeAccumulate—
9 Nov 2017KeybancMaintainsOverweight—
9 Nov 2017KeyBancMaintainsOverweight—
9 Nov 2017Monness Crespi HardtDowngradeNeutral—
9 Nov 2017Monness, Crespi, HardtDowngradeNeutral—
22 Aug 2017Monness Crespi HardtUpgradeBuy—
22 Aug 2017Monness, Crespi, HardtUpgradeBuy—
19 Dec 2016Monness Crespi HardtDowngradeNeutral—
19 Dec 2016Monness, Crespi, HardtDowngradeNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

IOSP appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
  • The AI build-out, every Wednesday: how AI stocks did, part by part.

Free. Unsubscribe any time.

Performance

IOSP vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 23 Oct 2026, Innospec, Inc. returned +33.4% against +14.3% for the S&P 500, dividends included.

IOSP vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120130140Jan 26Apr 26Jul 26Oct 26IOSPS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

IOSP analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+2.4%
Analysts raising
2
Analysts cutting
0
Fundamentals

Innospec, Inc. (IOSP) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
20.1×

Cheaper than 38% of US stocks

Price / sales
1.3×

Cheaper than 62% of US stocks

Price / book
1.8×

Cheaper than 46% of US stocks

EV / EBITDA
11.7×

Cheaper than 31% of US stocks

Growth & margins
Revenue growth (YoY)
11.8%

Higher than 57% of US stocks

Earnings growth (YoY)
31.1%

Higher than 66% of US stocks

Gross margin
28.1%

Higher than 31% of US stocks

Operating margin
8.1%

Higher than 61% of US stocks

Net margin
6.6%

Higher than 64% of US stocks

Returns & dividend
Return on equity
9.1%

Higher than 61% of US stocks

Return on assets
5.1%

Higher than 77% of US stocks

Dividend yield
1.9%

Higher than 78% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Innospec, Inc. (IOSP) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Innospec, Inc. has a market value of $2.4B and an enterprise value of $2.2B.

  • Revenue in the twelve months to 30 June 2026: $1.8B. The latest quarter grew 11.8% year on year.

  • Net income over the same four quarters: $122.3M, a 6.6% net margin.

  • Diluted earnings per share, trailing twelve months: $4.90.

  • Shares outstanding: 24.6M.

  • Trailing P/E: 20.1×; forward P/E: 16.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 1.87%, paying out 37% of earnings.

  • Innospec, Inc. employs 2,450 people — $752K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 25 Oct 2026

Data provided by Twelve Data

Peers

IOSP vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
IOSPInnospec, Inc.$2.4B84
NGVTIngevity Corp.$2.5B97
KWRQuaker Houghton$2.7B91
FULH.B. Fuller Co.$2.7B77
HWKNHawkins, Inc.$2.8B67
WDFCWD-40 Co.$2.9B86
MTXMinerals Technologies, Inc.$2.0B64

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Innospec, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest IOSP news & analysis

Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call

GlobeNewsWire · 5 Oct 2026neutral

Innospec Inc. announced it will release its third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. President and CEO Patrick S. Williams and CFO Ian Cleminson will host a conference call the following morning, November 4, 2026, at 9:00 a.m. ET.

Why it matters — This schedules the date and time for IOSP investors to hear the company's latest quarterly financial results and management commentary.

Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?

Zacks Investment Research · 3 Sept 2026positive

Innospec (IOSP) reported earnings 30 days ago, and its stock has risen 2% since that report. The article examines what may come next for the company's shares.

Why it matters — A Innospec watcher would track its post-earnings stock movement and outlook after the recent quarterly report.

4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand

Zacks Investment Research · 18 Aug 2026positive

Zacks Research reports that the Chemicals Diversified sector is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. The article names APD, DD, AVNT and IOSP as companies positioned to gain from strategic actions and demand recovery.

Why it matters — The report indicates that Innospec is among the diversified chemical stocks expected to benefit from stabilizing end-market demand and the conclusion of destocking.

Innospec: Topline Is Growing As Expected

Seeking Alpha · 12 Aug 2026neutral

Innospec's topline grew as expected in Q2 2026, with revenue up 12% and beating estimates by $34.17 million, led by the oilfield segment's DRA adoption and re-entry into the Mexico market. However, the Performance Chemicals segment continues to see volume declines, raising concerns about over-investment in capacity.

Why it matters — Investors should note that while topline growth is on track from oilfield and market expansion, ongoing weakness in the Performance Chemicals segment may weigh on overall returns for IOSP.

IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth

Zacks Investment Research · 7 Aug 2026positive

Innospec's second-quarter earnings surpassed estimates, driven by revenue growth across all three of its business segments. The company also maintains a debt-free balance sheet, which positions it for further investment.

Why it matters — The broad-based revenue growth and debt-free position indicate sound operational health and financial flexibility for future investment.

FAQ

Frequently asked questions about IOSP stock

What is the IOSP stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Innospec, Inc. have a median 12-month price target of $100, with estimates ranging from $93 to $110. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is IOSP stock a buy right now?

Of the 3 analysts covering Innospec, Inc., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Innospec, Inc. 84 out of 100 across roughly 4,600 US stocks as at 24 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank IOSP?

As at 24 Oct 2026, Innospec, Inc. ranks 84 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (81 of 100).

Will IOSP stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +1.4% from the last close, and Ticker Nerd's factor model ranks Innospec, Inc. 84 out of 100 as at 24 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the IOSP stock forecast for 2030?

No analyst covering Innospec, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for IOSP are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $93 to $110 over the next 12 months.

How has IOSP stock performed over the past year?

Innospec, Inc. returned +33.4% over the 12 months to 23 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Innospec, Inc. do?

Innospec Inc. is an international specialty chemicals company that develops, manufactures, blends, markets, and supplies performance-critical chemical solutions for industrial customers.

What is the latest news on IOSP?

The most recent item we track (GlobeNewsWire, 5 Oct 2026): "Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call". Innospec Inc. announced it will release its third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. President and CEO Patrick S. Williams and CFO Ian Cleminson will host a conference call the following morning, November 4, 2026, at 9:00 a.m. ET.

Company

About Innospec, Inc.

Innospec Inc. is an international specialty chemicals company that develops, manufactures, blends, markets, and supplies performance-critical chemical solutions for industrial customers. Innospec Inc. operates through three main business segments: Fuel Specialties, Performance Chemicals, and Oilfield Services. Its products include fuel additives that support engine performance and fuel efficiency, surfactants and specialty ingredients used in personal care and home care formulations, and chemicals for drilling, completion, and production operations in the oil and gas industry. The company also serves markets such as agrochemicals, construction, mining, polymers, and waxes, reflecting a broad industrial footprint. Innospec Inc. focuses on formulated, application-specific products rather than commodity chemicals, making it an important supplier across multiple end markets worldwide.

CEO Mr. Patrick S. Williams · 2,450 employees · United States · https://innospec.com